User profiles for S. Dhanasekaran

Saravana M Dhanasekaran

- Verified email at umich.edu - Cited by 33702

Dr. Sugapriya Dhanasekaran

- Verified email at psau.edu.sa - Cited by 705

[PDF][PDF] Proteogenomic data and resources for pan-cancer analysis

…, MJ Birrer, M Ceccarelli, SM Dhanasekaran… - Cancer cell, 2023 - cell.com
The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC)
investigates tumors from a proteogenomic perspective, creating rich multi-omics datasets …

Emerging role of adipocytokines in type 2 diabetes as mediators of insulin resistance and cardiovascular disease

…, R Ravindran, S Dhanasekaran - Canadian journal of …, 2018 - Elsevier
Adipose tissue is an enormously active endocrine organ, secreting various hormones, such
as adiponectin, leptin, resistin and visfatin, together with classical cytokines, such as tumor …

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran… - science, 2005 - science.org
Recurrent chromosomal rearrangements have not been well characterized in common
carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal …

The mutational landscape of lethal castration-resistant prostate cancer

…, YM Wu, DR Robinson, X Cao, SM Dhanasekaran… - Nature, 2012 - nature.com
Abstract Characterization of the prostate cancer transcriptome and genome has identified
chromosomal rearrangements and copy number gains and losses, including ETS gene family …

The polycomb group protein EZH2 is involved in progression of prostate cancer

S Varambally, SM Dhanasekaran, M Zhou, TR Barrette… - Nature, 2002 - nature.com
Prostate cancer is a leading cause of cancer-related death in males and is second only to
lung cancer. Although effective surgical and radiation treatments exist for clinically localized …

The landscape of long noncoding RNAs in the human transcriptome

…, S Zhao, A Poliakov, X Cao, SM Dhanasekaran… - Nature …, 2015 - nature.com
Long noncoding RNAs (lncRNAs) are emerging as important regulators of tissue physiology
and disease processes including cancer. To delineate genome-wide lncRNA expression, …

Delineation of prognostic biomarkers in prostate cancer

SM Dhanasekaran, TR Barrette, D Ghosh, R Shah… - Nature, 2001 - nature.com
Prostate cancer is the most frequently diagnosed cancer in American men 1 , 2 . Screening
for prostate-specific antigen (PSA) has led to earlier detection of prostate cancer 3 , but …

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

SA Tomlins, B Laxman, SM Dhanasekaran… - Nature, 2007 - nature.com
Recently, we identified recurrent gene fusions involving the 5′ untranslated region of the
androgen-regulated gene TMPRSS2 and the ETS (E26 transformation-specific) family genes …

Integrative molecular concept modeling of prostate cancer progression

…, L Wang, SM Dhanasekaran, S Kalyana-Sundaram… - Nature …, 2007 - nature.com
Despite efforts to profile prostate cancer, the genetic alterations and biological processes
that correlate with the observed histological progression are unclear. Using laser-capture …

[HTML][HTML] The landscape of circular RNA in cancer

…, L Xiao, Y Zhang, YM Wu, SM Dhanasekaran… - Cell, 2019 - cell.com
Circular RNAs (circRNAs) are an intriguing class of RNA due to their covalently closed structure,
high stability, and implicated roles in gene regulation. Here, we used an exome capture …